Posterior Reversible Encephalopathy Syndrome (PRES) in Rheumatic Autoimmune Disease

  • Izzat Khanjar Rheumatology Department, Hamad Medical Corporation, Doha, Qatar
  • Ibrahim Abdulmomen Rheumatology Department, Hamad Medical Corporation, Doha, Qatar
  • Yousef Yahia Rheumatology Department, Hamad Medical Corporation, Doha, Qatar
  • Abdul-Wahab Al-Allaf Rheumatology Department, Hamad Medical Corporation, Doha, Qatar

Keywords

PRES, posterior reversible encephalopathy syndrome, rheumatic autoimmune disease

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiological entity with many causes. The primary abnormality is cerebral vasogenic oedema. Here we describe the management of five patients with PRES syndrome who presented to our hospital.

VIEW THE ENTIRE ARTICLE

References

  • Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.

  • Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic oedema. AJNR Am J Neuroradiol 2008;29:1043–1049.

  • Casey SO, Sampaio RC, Michel E, et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199–1206.

  • McKinney AM, Short J, Truwit CL et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol 2007;189:904–912.

  • Vincent JL (ed). Annual update in intensive care and emergency medicine 2011. New York: Springer, 813 pp.

  • Rahmanzadeh R, Rahmanzade R, Zabihiyeganeh M. Posterior reversible encephalopathy syndrome in a patient with mixed connective tissue disease: a case report. J Med Case Rep 2016;10:145.

  • Burnett MM, Hess CP, Roberts JP, et al. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 2010;112:886–889.

  • Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85:427–432.

  • Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379–383.

  • Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit 2005;11:CR549–53.

  • Abe T, Tokuda Y. Recurrent posterior reversible encephalopathy syndrome of the brainstem in a hypertensive patient with end-stage renal disease. J Emerg Trauma Shock 2014;7:242–243.

  • Roy S, Gandhi AK, Jana M, Julka PK. Recurrent posterior reversible encephalopathy syndrome after chemotherapy in hematologic malignancy-posterior reversible encephalopathy syndrome can strike twice!!! J Cancer Res Ther 2014;10:393–396.
  • Published: 2018-03-27

    Issue: Vol 5 No 6 (view)

    Section: Articles

    How to cite:
    Khanjar, I., Abdulmomen, I., Yahia, Y., & Al-Allaf, A.-W. (2018). Posterior Reversible Encephalopathy Syndrome (PRES) in Rheumatic Autoimmune Disease. European Journal of Case Reports in Internal Medicine, 5(6). https://doi.org/https://doi.org/10.12890/2018_000866